Elevated Serum Level of Interleukin 17 in a Population With Prehypertension

Journal of Clinical Hypertension

Volumn 17, Issue 10, 2015, Pages 770-774

  Yao, Wei ^a   Sun, Yuemin ^a   Wang, Xuechun ^a   Niu, Kaijun ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 17; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID; IL17A PROTEIN, HUMAN;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; BODY MASS; CHINA; COHORT ANALYSIS; CYTOKINE BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREHYPERTENSION; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; ANTHROPOMETRY; BLOOD; BLOOD PRESSURE; HYPERTENSION; MIDDLE AGED; ODDS RATIO; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RISK FACTOR;

AGED; ANTHROPOMETRY; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CHINA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERTENSION; INTERLEUKIN-17; MALE; MIDDLE AGED; ODDS RATIO; PREHYPERTENSION; RISK ASSESSMENT; RISK FACTORS;

EID: 84942833551     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12612     Document Type: Article

References (21)

1. Harrison DG, Guzik TJ, Goronzy J, Weyand C. Is hypertension an immunologic disease? Curr Cardiol Rep. 2008;10:464-469.
2. Virdis A, Schiffrin EL. Vascular inflammation: a role in vascular disease in hypertension? Curr Opin Nephrol Hypertens. 2003;12:181-187.
3. Savoia C, Schiffrin EL. Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. Clin Sci. 2007;112:375-384.
4. Svendsen UG. Evidence for an initial, thymus independent and a chronic, thymus dependent phase of DOCA and salt hypertension in mice. Acta Pathol Microbiol Scand A. 1976;84:523-528.
5. Bataillard A, Freiche JC, Vincent M, et al. Antihypertensive effect of neonatal thymectomy in the genetically hypertensive LH rat. Thymus. 1986;8:321-330.
6. Rodriguez-Iturbe B, Quiroz Y, Nava M, et al. Reduction of renal immune cell infiltration result in blood pressure control in genetically hypertensive rats. Am J Physiol Renal Physiol. 2002;282:F191-F201.
7. Guzik TJ, Hoch NE, Brown KA, et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med. 2007;204:2449-2460.
8. Dong C. Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat Rev Immunol. 2006;6:329-333.
9. Tesmer LA, Lundy SK, Sarkar S, et al. Th17 cells in human disease. Immunol Rev. 2008;223:87-113.
10. Eid RE, Rao DA, Zhou J, et al. Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation. 2009;119:1424-1432.
11. Madhur MS, Lob HE, McCann LA, et al. Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension. 2010;55:500-507.
12. Chobanian AV, Bakris GL, Black HR, et al.; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National High Blood Pressure Education Program Coordinating Committee. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
13. Natali A, Muscelli E, Casolaro A, et al. Metabolic characteristics of prehypertension: role of classification criteria and gender. J Hypertens. 2009;27:2394-2402.
14. Fung MM, Rao F, Poddar S, et al. Early inflammatory and metabolic changes in association with AGTR1 polymorphisms in prehypertensive subjects. Am J Hypertens. 2011;24:225-233.
15. Chrysohoou C, Panagiotakos DB, Pitsavos C, et al. The association between prehypertension status and oxidative stress markers related to atherosclerosis disease: the ATTICA study. Atherosclerosis. 2007;192:169-176.
16. Wang G, Wang A, Tong W, et al. Association of elevated inflammatory and endothelial biomarkers with prehypertension among Mongolians in China. Hypertens Res. 2011;34:516-520.
17. Navarro-Gonzalez JF, Mora C, Muros M, et al. Relationship between inflammation and microalbuminuria in prehypertension. J Hum Hypertens. 2013;27:119-125.
18. Eriksson EE, Xie X, Werr J, et al. Importance of primary capture and L-selectindependent secondary capture in leukocyte accumulation in inflammation and atherosclerosis in vivo. J Exp Med. 2001;194:205-218.
19. Yao Z, Painter SL, Fanslow WC, et al. Human IL-17: a novel cytokine derived from T cells. J Immunol. 1995;155:5483-5486.
20. Zhang X, Jin J, Peng X, et al. Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes. J Immunol. 2008;180:6988-6996.
21. Platten M, Youssef S, Hur EM, et al. Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity. Proc Natl Acad Sci USA. 2009;106:14948-14953.